Skin Cancer Market Report

Global and Region Skin Cancer Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：221
  • REPORT CODE：GMM920113
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Skin Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Skin Cancermarket, defines the market attractiveness level of Skin Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Skin Cancer industry, describes the types of Skin Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Skin Cancer market and the development prospects and opportunities of Skin Cancer industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Skin Cancer market in Chapter 13.

    By Player:

    • Oncothyreon Inc (Switzerland)

    • Novartis International AG (Switzerland)

    • Merck & Co Inc (India)

    • F Hoffmann-la Roche Ltd (Sweden)

    • Eli Lilly and Co (US)

    • Valeant Pharmaceuticals Inc (US)

    • Cannabis Science Inc (US)

    • Bristol Myers Squibb Co (Denmark)

    • Boehringer Ingelheim GmbH (Sweden)

    • LEO Pharma A/S (US)

    • Moberg Pharma AB (US)

    • iCAD Inc (US)

    • Aqua Pharmaceuticals LLC (US)

    • Cellceutix Corp (Germany)

    • Meda AB (US)

    • Elekta AB (Canada)

    • Mylan Pharmaceutical Inc (US)

    • Varian Medical Systems Inc (Sweden)

    • Sun Pharma Industries Ltd (US)

    By Type:

    • Basal Cell Carcinoma

    • Squamous Cell Carcinoma

    By End-User:

    • Hospital

    • Clinics

    • Diagnostic Centers

    • Cancer Research Institute

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Skin Cancer Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Skin Cancer Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Skin Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Skin Cancer Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Skin Cancer Market Analysis and Outlook to 2022

    • 7.1 Global Skin Cancer Consumption (2017-2022)

    • 7.2 United States Skin Cancer Consumption (2017-2022)

    • 7.3 Europe Skin Cancer Consumption (2017-2022)

    • 7.4 China Skin Cancer Consumption (2017-2022)

    • 7.5 Japan Skin Cancer Consumption (2017-2022)

    • 7.6 India Skin Cancer Consumption (2017-2022)

    • 7.7 South Korea Skin Cancer Consumption (2017-2022)

    8 Region and Country-wise Skin Cancer Market Analysis and Outlook to 2028

    • 8.1 Global Skin Cancer Consumption Forecast (2022-2028)

    • 8.2 United States Skin Cancer Consumption Forecast (2022-2028)

    • 8.3 Europe Skin Cancer Consumption Forecast (2022-2028)

    • 8.4 China Skin Cancer Consumption Forecast (2022-2028)

    • 8.5 Japan Skin Cancer Consumption Forecast (2022-2028)

    • 8.6 India Skin Cancer Consumption Forecast (2022-2028)

    • 8.7 South Korea Skin Cancer Consumption Forecast (2022-2028)

    9 Global Skin Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Skin Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Basal Cell Carcinoma Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)

    • 9.2 Global Skin Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cancer Research Institute Consumption and Growth Rate (2017-2022)

    10 Global Skin Cancer Market Outlook by Types and Applications to 2028

    • 10.1 Global Skin Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Basal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Skin Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cancer Research Institute Consumption Forecast and Growth Rate (2022-2028)

    11 Global Skin Cancer Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Skin Cancer Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Skin Cancer Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Skin Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Skin Cancer Market Competitive Analysis

    • 14.1 Oncothyreon Inc (Switzerland)

      • 14.1.1 Oncothyreon Inc (Switzerland) Company Details

      • 14.1.2 Oncothyreon Inc (Switzerland) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Oncothyreon Inc (Switzerland) Skin Cancer Product and Service

    • 14.2 Novartis International AG (Switzerland)

      • 14.2.1 Novartis International AG (Switzerland) Company Details

      • 14.2.2 Novartis International AG (Switzerland) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis International AG (Switzerland) Skin Cancer Product and Service

    • 14.3 Merck & Co Inc (India)

      • 14.3.1 Merck & Co Inc (India) Company Details

      • 14.3.2 Merck & Co Inc (India) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck & Co Inc (India) Skin Cancer Product and Service

    • 14.4 F Hoffmann-la Roche Ltd (Sweden)

      • 14.4.1 F Hoffmann-la Roche Ltd (Sweden) Company Details

      • 14.4.2 F Hoffmann-la Roche Ltd (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-la Roche Ltd (Sweden) Skin Cancer Product and Service

    • 14.5 Eli Lilly and Co (US)

      • 14.5.1 Eli Lilly and Co (US) Company Details

      • 14.5.2 Eli Lilly and Co (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly and Co (US) Skin Cancer Product and Service

    • 14.6 Valeant Pharmaceuticals Inc (US)

      • 14.6.1 Valeant Pharmaceuticals Inc (US) Company Details

      • 14.6.2 Valeant Pharmaceuticals Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Valeant Pharmaceuticals Inc (US) Skin Cancer Product and Service

    • 14.7 Cannabis Science Inc (US)

      • 14.7.1 Cannabis Science Inc (US) Company Details

      • 14.7.2 Cannabis Science Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cannabis Science Inc (US) Skin Cancer Product and Service

    • 14.8 Bristol Myers Squibb Co (Denmark)

      • 14.8.1 Bristol Myers Squibb Co (Denmark) Company Details

      • 14.8.2 Bristol Myers Squibb Co (Denmark) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bristol Myers Squibb Co (Denmark) Skin Cancer Product and Service

    • 14.9 Boehringer Ingelheim GmbH (Sweden)

      • 14.9.1 Boehringer Ingelheim GmbH (Sweden) Company Details

      • 14.9.2 Boehringer Ingelheim GmbH (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim GmbH (Sweden) Skin Cancer Product and Service

    • 14.10 LEO Pharma A/S (US)

      • 14.10.1 LEO Pharma A/S (US) Company Details

      • 14.10.2 LEO Pharma A/S (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 LEO Pharma A/S (US) Skin Cancer Product and Service

    • 14.11 Moberg Pharma AB (US)

      • 14.11.1 Moberg Pharma AB (US) Company Details

      • 14.11.2 Moberg Pharma AB (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Moberg Pharma AB (US) Skin Cancer Product and Service

    • 14.12 iCAD Inc (US)

      • 14.12.1 iCAD Inc (US) Company Details

      • 14.12.2 iCAD Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 iCAD Inc (US) Skin Cancer Product and Service

    • 14.13 Aqua Pharmaceuticals LLC (US)

      • 14.13.1 Aqua Pharmaceuticals LLC (US) Company Details

      • 14.13.2 Aqua Pharmaceuticals LLC (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Aqua Pharmaceuticals LLC (US) Skin Cancer Product and Service

    • 14.14 Cellceutix Corp (Germany)

      • 14.14.1 Cellceutix Corp (Germany) Company Details

      • 14.14.2 Cellceutix Corp (Germany) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Cellceutix Corp (Germany) Skin Cancer Product and Service

    • 14.15 Meda AB (US)

      • 14.15.1 Meda AB (US) Company Details

      • 14.15.2 Meda AB (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Meda AB (US) Skin Cancer Product and Service

    • 14.16 Elekta AB (Canada)

      • 14.16.1 Elekta AB (Canada) Company Details

      • 14.16.2 Elekta AB (Canada) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Elekta AB (Canada) Skin Cancer Product and Service

    • 14.17 Mylan Pharmaceutical Inc (US)

      • 14.17.1 Mylan Pharmaceutical Inc (US) Company Details

      • 14.17.2 Mylan Pharmaceutical Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Mylan Pharmaceutical Inc (US) Skin Cancer Product and Service

    • 14.18 Varian Medical Systems Inc (Sweden)

      • 14.18.1 Varian Medical Systems Inc (Sweden) Company Details

      • 14.18.2 Varian Medical Systems Inc (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Varian Medical Systems Inc (Sweden) Skin Cancer Product and Service

    • 14.19 Sun Pharma Industries Ltd (US)

      • 14.19.1 Sun Pharma Industries Ltd (US) Company Details

      • 14.19.2 Sun Pharma Industries Ltd (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Sun Pharma Industries Ltd (US) Skin Cancer Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Skin Cancer

    • Figure Skin Cancer Picture

    • Table Global Skin Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Skin Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Skin Cancer Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Skin Cancer Consumption by Country (2017-2022)

    • Figure United States Skin Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure China Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Basal Cell Carcinoma Consumption and Growth Rate (2017-2022)

    • Figure Global Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Research Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Basal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Research Institute Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Skin Cancer Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Skin Cancer Export by Region (Top 5 Countries) (2017-2028)

    • Table Oncothyreon Inc (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Oncothyreon Inc (Switzerland) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oncothyreon Inc (Switzerland) Skin Cancer Product and Service

    • Table Novartis International AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG (Switzerland) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG (Switzerland) Skin Cancer Product and Service

    • Table Merck & Co Inc (India) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc (India) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc (India) Skin Cancer Product and Service

    • Table F Hoffmann-la Roche Ltd (Sweden) (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-la Roche Ltd (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-la Roche Ltd (Sweden) Skin Cancer Product and Service

    • Table Eli Lilly and Co (US) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Co (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Co (US) Skin Cancer Product and Service

    • Table Valeant Pharmaceuticals Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Inc (US) Skin Cancer Product and Service

    • Table Cannabis Science Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Cannabis Science Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cannabis Science Inc (US) Skin Cancer Product and Service

    • Table Bristol Myers Squibb Co (Denmark) (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Co (Denmark) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Co (Denmark) Skin Cancer Product and Service

    • Table Boehringer Ingelheim GmbH (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH (Sweden) Skin Cancer Product and Service

    • Table LEO Pharma A/S (US) (Foundation Year, Company Profile and etc.)

    • Table LEO Pharma A/S (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma A/S (US) Skin Cancer Product and Service

    • Table Moberg Pharma AB (US) (Foundation Year, Company Profile and etc.)

    • Table Moberg Pharma AB (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moberg Pharma AB (US) Skin Cancer Product and Service

    • Table iCAD Inc (US) (Foundation Year, Company Profile and etc.)

    • Table iCAD Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table iCAD Inc (US) Skin Cancer Product and Service

    • Table Aqua Pharmaceuticals LLC (US) (Foundation Year, Company Profile and etc.)

    • Table Aqua Pharmaceuticals LLC (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aqua Pharmaceuticals LLC (US) Skin Cancer Product and Service

    • Table Cellceutix Corp (Germany) (Foundation Year, Company Profile and etc.)

    • Table Cellceutix Corp (Germany) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellceutix Corp (Germany) Skin Cancer Product and Service

    • Table Meda AB (US) (Foundation Year, Company Profile and etc.)

    • Table Meda AB (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meda AB (US) Skin Cancer Product and Service

    • Table Elekta AB (Canada) (Foundation Year, Company Profile and etc.)

    • Table Elekta AB (Canada) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elekta AB (Canada) Skin Cancer Product and Service

    • Table Mylan Pharmaceutical Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Mylan Pharmaceutical Inc (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharmaceutical Inc (US) Skin Cancer Product and Service

    • Table Varian Medical Systems Inc (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Varian Medical Systems Inc (Sweden) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Varian Medical Systems Inc (Sweden) Skin Cancer Product and Service

    • Table Sun Pharma Industries Ltd (US) (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Industries Ltd (US) Skin Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Industries Ltd (US) Skin Cancer Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US